title: CT pulmonary angiography after total joint arthroplasty: overdiagnosis and iatrogenic harm?
abstract: BACKGROUND
  CT pulmonary angiography (CTPA) has become widely adopted to detect pulmonary embolism (PE) after total joint arthroplasty (TJA). CTPA is a sensitive tool, which has the ability to detect emboli that may be clinically insignificant. This may lead to iatrogenic harm from overtreatment.
  
  
  OBJECTIVE
  The purpose of this study was to assess changing prevalence, mortality, treatment complications, and resource consumption associated with PE after TJA before and after the introduction of CTPA.
  
  
  METHODS
  The Nationwide Inpatient Sample was used to identify 2,335,248 patients undergoing TJA from 1993 to 1998 before the introduction of CTPA and 6,321,671 patients from 1999 to 2008 after the introduction of CTPA. Bivariate and multivariate regression analysis was performed to compare changing prevalence of PE, mortality, potential treatment complications of anticoagulation, length of stay, and total charges before and after the introduction of CTPA in patients with PE.
  
  
  RESULTS
  In-hospital diagnosis of PE after TJA increased (p < 0.001) from an average of 0.27% to 0.37% after the introduction of CTPA. All-cause mortality in patients with a diagnosis of PE decreased (p < 0.001) from 11.5% to 4.6% (odds ratio, 2.3; 95% confidence interval, 2.1-2.6) after the introduction of CTPA. Overall, PE was associated with increased (p < 0.001) risks for hematoma/seroma, postoperative infection, gastrointestinal bleed, and drug-related thrombocytopenia, although the prevalence of these complications has decreased after 1998 (p < 0.001). Length of stay doubled for patients with PE (both before and after CTPA) and total charges increased over 69% in both study periods for these patients.
  
  
  CONCLUSIONS
  Adoption of CTPA appears to be associated with an increase in the diagnosis of PE after TJA and an associated decrease in case-fatality. Although CTPA may improve our ability to diagnose PE and possibly reduce mortality, the observed decrease in case-fatality could also be explained by the overdiagnosis of clinically unimportant emboli. The diagnosis of PE was strongly associated with potential iatrogenic harm from anticoagulation and increased length of stay and hospital charges in this study, emphasizing the importance of further investigation to define the role of CTPA in the diagnosis and treatment of PE after TJA.
authors: Department of Orthopaedic Surgery, University of Virginia, PO Box 800159, Charlottesville, VA 22908, USA.
authors: Michele R
authors: MR
authors: D'Apuzzo
authors: Thomas C
authors: TC
authors: Keller
authors: Wendy M
authors: WM
authors: Novicoff
authors: James A
authors: JA
authors: Browne
mesh_terms: D019643:Arthroplasty, Replacement / Q000009:adverse effects* / Q000401:mortality; D006801:Humans; D007049:Iatrogenic Disease / Q000453:epidemiology*; D007902:Length of Stay; D015995:Prevalence; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000209:etiology; D011859:Radiography
references: N Engl J Med. 2003 Oct 30;349(18):1703-12
references: 14585938
references: Clin Orthop Relat Res. 2010 Jan;468(1):115-9
references: 19669848
references: J Am Coll Surg. 2009 May;208(5):871-8; discussion 878-80
references: 19476851
references: Arch Intern Med. 1998 Jul 27;158(14):1525-31
references: 9679793
references: J Bone Joint Surg Br. 2006 Mar;88(3):386-91
references: 16498018
references: J Bone Joint Surg Am. 2008 Nov;90(11):2331-6
references: 18978401
references: J Bone Joint Surg Br. 2007 Jun;89(6):799-807
references: 17613508
references: Ann Pharmacother. 2004 Mar;38(3):377-82
references: 14742829
references: J Bone Joint Surg Am. 2007 Jan;89(1):33-8
references: 17200307
references: J Arthroplasty. 2007 Sep;22(6 Suppl 2):24-8
references: 17823010
references: J Bone Joint Surg Br. 2005 Dec;87(12):1675-80
references: 16326885
references: Arch Intern Med. 2002 Jul 8;162(13):1465-71
references: 12090882
references: J Natl Cancer Inst. 2010 May 5;102(9):605-13
references: 20413742
references: J Bone Joint Surg Br. 2002 May;84(4):566-70
references: 12043780
references: J Bone Joint Surg Am. 2005 Oct;87(10):2169-77
references: 16203879
references: Clin Orthop Relat Res. 2010 Jan;468(1):45-51
references: 19554385
references: J Clin Epidemiol. 1992 Jun;45(6):613-9
references: 1607900
references: J Bone Joint Surg Br. 2000 Aug;82(6):795-800
references: 10990299
references: Blood. 2009 Jul 30;114(5):952-6
references: 19439733
references: Clin Orthop Relat Res. 2003 Oct;(415):180-92
references: 14612645
references: N Engl J Med. 1998 Feb 12;338(7):409-15
references: 9459643
references: Conn Med. 2010 Jan;74(1):5-9
references: 20175366
references: Acta Orthop Belg. 2005 Feb;71(1):55-9
references: 15792208
references: J Thorac Imaging. 2004 Jul;19(3):164-70
references: 15273612
references: J Bone Joint Surg Br. 2005 Nov;87(11):1465-7
references: 16260659
references: J Comput Assist Tomogr. 2008 May-Jun;32(3):421-5
references: 18520550
references: J Bone Joint Surg Am. 2009 Jan;91(1):128-33
references: 19122087
references: J Bone Joint Surg Br. 2003 Jul;85(5):661-5
references: 12892186
references: Clin Orthop Relat Res. 2000 Jun;(375):168-74
references: 10853166
references: J Arthroplasty. 2003 Feb;18(2):180-5
references: 12629608
references: Chest. 2009 Oct;136(4):983-990
references: 19525357
references: J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38
references: 10901307
references: Arch Intern Med. 2011 May 9;171(9):831-7
references: 21555660